Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05311488 · ClinicalTrials.gov registry record
Early Detection of Neuropathy in ATTRv
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 47
- Enrollment target
NCT05311488: Completed study, sponsored by University of Pennsylvania.
NCT05311488 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05311488 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate and compare different tools that are used to detect evidence of peripheral neuropathy in patients with TTRv.
Interventions
- DIAGNOSTIC_TEST neurofilament light chain
- DIAGNOSTIC_TEST In-vivo Meissner Corpuscle imaging
- DIAGNOSTIC_TEST Nerve conduction study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2026-02-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05311488
The ClinicalTrials.gov registry entry for NCT05311488 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which neurofilament light chain is the first listed.
NCT05311488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05311488 about?
NCT05311488 is a clinical study titled "Early Detection of Neuropathy in ATTRv". The purpose of the study is to evaluate and compare different tools that are used to detect evidence of peripheral neuropathy in patients with TTRv.
What is the current status of trial NCT05311488?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2022-02-14. Estimated completion is 2026-02-14.
What interventions are being tested in trial NCT05311488?
The interventions under investigation include: neurofilament light chain (DIAGNOSTIC_TEST), In-vivo Meissner Corpuscle imaging (DIAGNOSTIC_TEST), Nerve conduction study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05311488?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.